San Francisco, March 10, 2016 -- Deceptive representation of an original food product and pharmaceutical is referred to as counterferfeiting. Increasing growth of low quality and cheap counterfeit products mainly pertaining to the food and pharmaceuticals industries have promoted the rate of implementation of anti-counterfeiting technologies. Trace technologies, covert features enabling and overt/visible feature are some of the key technologies associated with anti-counterfeiting. The U.S FDA stated that, Pharmaceutical manufacturers in the U.S suffer revenue loss of USD 300 billion everywhere .This was mainly due to the counterfeiting in the region. On addition, these products also affect the brand image of the original manufacturer as they achieve low on quality.
Rising awareness levels of regulatory authorities like the U.S FDA coupled with manufacturers’ losses in terms of brand image and revenue is likely to boost the anti-counterfeiting technologies market.
Browse to access In-depth research report on Global Pharmaceuticals And Food Anti-Counterfeiting Technologies Market with detailed charts and figures: http://www.grandviewresearch.com/industry-analysis/pharmaceuticals-and-food-anti-counterfeiting
Abundant existence of untapped opportunities in Asian countries with increased counterfeiting occurrences in china coupled with Augmenting demand for advanced technologies like ultra high RFID tags is expected to boost the industry growth over the coming years. China contributes for over 70% of the total customs seizures according to the report published by World Customs Organization.
In 2012, bar codes segment dominated the worldwide pharmaceutical and food anti-counterfeiting technologies market. Advanced existence of high market penetration rates of this technology in food and drugs industries mainly pertaining to the packaging and inventory management facets displayed by this technology will drive the industry. RFID based technology acts as the driver for the overall market as the technology is relatively cheaper as compared to others.
Request for free sample of this research report: http://www.grandviewresearch.com/industry-analysis/pharmaceuticals-and-food-anti-counterfeiting/request
In terms of revenue, Pharmaceutical anti-counterfeiting applications dominated the entire market in 2013. It contributed the market share of over USD 40 billion in the year 2012. Increasing adoption rates of anti- counterfeiting in the pharmaceuticals sector is the major factor boosting the market. Furthermore, food counterferfeiting technologies industry is likely to undergo a highest CAGR over the coming years. This is mainly due to rising awareness levels of manufacturers and existence of a constantly advancing infrastructure that support the execution of these technologies
In terms of revenue share, North America dominated the overall market for anti-counterfeiting technologies in the year 2012.Implementation of strict and diligent regulations by the FDA coupled with existence of sophisticated healthcare infrastructure in the region are the factors expected to drive the market further.
Browse related reports by Grand View Research:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-pharmaceuticals-and-food-anti-counterfeiting
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
email: [email protected]
Web: www.grandviewresearch.com


Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 



